Upload
aymeth-euribe
View
215
Download
0
Embed Size (px)
Citation preview
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 1/16
UNIT 12.13Determination of Cholinesterase in Bloodand Tissue
Barry W. Wilson1 and John D. Henderson1
1University of California, Davis, California
ABSTRACT
The widespread use of organophosphate and organocarbamate pesticides and the dan-gers of related chemical warfare agents dramatize the importance of rapid, accurate,
and sensitive assays for blood and tissue cholinesterases (ChEs), important targets for
neurotoxic chemicals. Two ChE enzymes used as biomarkers of exposure are the specific
acetylcholinesterases (AChE, EC 3.1.1.7) and the nonspecific plasma cholinesterases
(BChE, EC 3.1.1.8). This unit contains two protocols for measuring ChE activity: (1) a
colorimetric kinetic method and (2) a radiometric endpoint assay and selective inhibitors
that are used to distinguish between the two classes of enzymes. Curr. Protoc. Toxicol.
34:12.13.1-12.13.16. C 2007 by John Wiley & Sons, Inc.
Keywords: cholinesterases r colorimetric assay r radiometric assay r delta pH assay
INTRODUCTION
Acetylcholine (ACh) is an important neurotransmitter. Its action at synapses is regulated
by its hydrolysis by acetylcholinesterase (AChE, EC 3.1.1.7). AChE and related enzymes,
known as nonspecific or pseudocholinesterases (BChE, EC 3.1.1.8), are found in nerve,
muscle, blood, and other tissues. Natural organocarbamates, such as physostigmine
found in the calabar bean, synthetic organophosphate (OP) and organocarbamate (OC)
pesticides, and chemical warfare agents act by inhibiting AChE. AChE and BChE activity
levels are recognized biomarkers of exposure to these agents and their determinations
are important tools in neurotoxicology.
Basic Protocol 1 describes colorimetric determination of ChE and Basic Protocol 2
describes radiometric determination of ChE. Basic Protocol 1 uses 96-well microtiter plates, the synthetic substrate acetylthiocholine (ATCh), and is designed for efficient
throughput of samples. Basic Protocol 2 uses the natural substrate ACh. It is useful
for samples with low ChE activity, but it takes longer to produce results and generates
radioactive waste. Support Protocol 1 describes tissue preparation and Support Protocol
2 provides an instrument-specific calculation factor for generating a free sulfhydryl
standard curve resulting from the colorimetric method. Support Protocol 3 optimizes
the concentration when measuring samples from a new species and produces a substrate
concentration curve. Support Protocol 4 lists useful inhibitors of ChEs.
BASIC
PROTOCOL 1
COLORIMETRIC DETERMINATION OF CHOLINESTERASE
The rate of hydrolysis of acetylthiocholine (ATCh) catalyzed by cholinesterases (ChEs) isdetermined colorimetrically with an automated microtiter plate reader and a colorimetric
reagent that detects sulfhydryl groups (–SH). ATCh is incubated with the tissue sam-
ple and the color reagent, 5,5-dithiobis-2-nitrobenzoic acid (DTNB). The thiocholine
produced by the hydrolysis of the substrate reacts with DTNB to yield a yellow colored
anion, 5-thio-2-nitrobenzoate (TNB). The formation of TNB is followed kinetically using
the microtiter plate reader. There are two different blanks. An enzyme blank (no substrate
present) detects free sulfhydryls that may be present in the sample. The SH-compounds
Current Protocols in Toxicology 12.13.1-12.13.16, November 2007
Published online November 2007 in Wiley Interscience (www.interscience.wiley.com).
DOI: 10.1002/0471140856.tx1213s34
Copyright C 2007 John Wiley & Sons, Inc.
Biochemical andMolecularNeurotoxicology
12.13.1
Supplement 34
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 2/16
Determination of Cholinesterase inBlood and Tissue
12.13.2
Supplement 34 Current Protocols in Toxicology
react directly with DTNB to give TNB. A substrate blank (no sample present) shows the
amount of color formation due to non-enzymatic hydrolysis of ATCh.
Materials
DTNB color reagent (see recipe)
ChE assay buffer (see recipe)
ATCh substrate (see recipe)
Automated microtiter plate reader (with plate shaker and temperature control,capable of kinetic measurements and electronic data storage)
Heating block
Temperature probe (small enough to fit into a well of a 96-well microtiter plate)
Repeater pipettors and disposable syringe-type tips (Eppendorf or equivalent)
96-well flat-bottomed microtiter plates
1. Turn on power to the microtiter plate reader. Allow the instrument to warm up
according to manufacturer’s recommendations.
2. Set the temperature control on the microtiter plate reader to maintain the plate at
25◦C.
This will need to be determined for each particular instrument. It is usually a temperature>25◦C (30◦C for some instruments).
3. Set the wavelength on the microtiter plate reader to 412 nm.
For instruments using narrow-band interference filters, the commonly supplied 405-nm
filter is satisfactory.
4. Set the time interval between absorbance readings to 2 min and the number of
readings to six.
This provides a determination with a low background. Samples with high activity may
need a shorter time interval (although dilution of the sample is preferable).
5. Turn on the heating block. Set the temperature to warm a microtiter plate and its
contents to 25◦C.
Determine this temperature for the specific equipment (the authors use 34◦
to 35◦
C).
6. Turn on the temperature probe and calibrate according to the manufacturer’s recom-
mendations.
7. Diagram the specific sample layout in the 96-well microtiter plate on a grid template.
The microtiter plate contains 96 wells arranged in eight horizontal rows (lettered Athrough H) and twelve vertical columns (numbered 1 through 12). In the authors’ assays,
the samples are usually run in triplicate in consecutive wells within a row (e.g., B7 to B9,C4 to C6, etc.). Fill in a template as shown in Figure 12.13.1 to show which samples or
blanks are in which wells.
8. Add solutions to the wells, referring to Table 12.13.1 for appropriate volumes.
a. Add DTNB color reagent and ChE assay buffer.
b. Add the samples.
c. Add the ATCh substrate using a repeater pipettor (with syringe-type tip) to start
the assay.
The repeater pipettor with syringe-type tip provides better mixing of the well contentsthan a plate-shaker.
9. Place the microtiter plate into the plate reader without delay.
10. Check the temperature with the probe and record.
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 3/16
Biochemical andMolecularNeurotoxicology
12.13.3
Current Protocols in Toxicology Supplement 34
Figure 12.13.1 A 96-well microtiter plate assay form template. Microtiter plate well designations
(e.g., sample IDs, controls, blanks) should be labeled on the form and referred to while performing
the colorimetric assay.
Table 12.13.1 Colorimetric Assay Volumesa
ReagentChE sample
(µ l)
Tissue blank
(µ l)
Substrate
blank (µ l)
Final
concentration
ChE assay buffer 250 280 280 —
DTNB color reagent 10 10 10 0.32 mM
Sample 30 30 — —
ATCh substrate 30 — 30 1.0 mM
aFinal volume = 320µl.
11. Start measurements.
12. When the plate is finished being read, check the temperature with the probe again
and record.
13. Calculate activity by performing the following:
a. Take the mean of the slopes for each triplicate set of samples. This gives the mean
A /min (the change in absorbance per minute).
b. Convert the A /min to µ mol/min/ml:
Equation 12.13.1
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 4/16
Determination of Cholinesterase inBlood and Tissue
12.13.4
Supplement 34 Current Protocols in Toxicology
where the factor is an instrument-specific calculation factor that must be deter-
mined (see Support Protocol 2).
c. If total ChE and AChE assays were run on the same sample, the nonspecific ChE(BChE) is calculated by subtracting the AChE value from the total ChE value(see Support Protocol 4).
d. Divide the value by the protein concentration of the sample (mg/ml) to yieldenzyme activity as µ mol/min/mg protein.
BASIC
PROTOCOL 2
RADIOMETRIC DETERMINATION OF CHOLINESTERASE
Tritiated ACh is incubated with the sample for a predetermined time in this end-point
assay. The reaction is stopped by adding a solution that is basic, high in salt, and contains
an excess of an analog of acetic acid (one of the reaction end-products). A toluene-based
fluor is mixed with the sample and there is a separation of the aqueous and organic
phases. The unhydrolyzed ACh preferentially enters the aqueous phase, quenching its
radioactivity. The hydrolyzed labeled acetate remains in the fluor solvent phase, where it
can be measured with a scintillation counter. Commercially available electric eel AChE
is added in excess to control vials to hydrolyze all the ACh to determine the total counts
per million (cpm) in the vials.
Materials
ChE enzyme sample
100 U/ml eel AChE (see recipe)
ChE assay buffer (see recipe)
10 µ Ci/ml (10 mM) 3H-acetylcholine (ACh) substrate (see recipe)
Stopping mixture (see recipe)
Fluor (see recipe)
5-ml disposable scintillation vials with caps (e.g., Packard Pony vials cat. no.6000292)
Vial racks
Tabletop shaker
Scintillation counter
1. Set out three 5-ml vials in a rack for each sample, eel AChE control, and blanks (no
sample).
2. Add to each vial: ChE enzyme sample and ChE assay buffer to a volume of 80 µ l as
listed in Table 12.13.2.
A useful way to determine if solutions were added is to tilt the rack containing the vials,checking the meniscus visually in each vial to be certain no reagent addition was missed.
3. Initiate the assay by adding 20 µ l of 10 µ Ci/ml 3H-ACh substrate to each vial. Begin
timing when the first vial is started.
4. Run the assay for 15 to 40 min at room temperature in a shaker. Note temperature.
5. Stop the reaction by adding 100 µ l stopping mixture to each vial in the same order
in which the assay was begun.
6. Add 4 ml of fluor to each vial.
7. Cap each vial. Shake vigorously. Allow phases to separate for 30 min.
8. Count samples in a scintillation counter set for the 3H energy spectrum.
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 5/16
Biochemical andMolecularNeurotoxicology
12.13.5
Current Protocols in Toxicology Supplement 34
Table 12.13.2 Radiometric Assay Volumesa
Reagent Eel AChE (µ l) Blank (µ l) ChE sample (µ l)
Assay buffer 70 80 60
Eel AChE 10 — —
Sample — — 20
3H-ACh substrate 20 20 20
aFinal volume = 100µl; final substrate concentration is 2.0 mM.
9. Calculate the activity (µ mol ACh hydrolyzed/min/ml):
Equation 12.13.2
The amount of micromoles of substrate added is 0.2.
The sample cpm should not be >50% of the completely hydrolyzed eel cpm to keep theassay reaction within its linear range.
It is prudent to determine the dpm and use it in the calculations (see Critical Parametersand Troubleshooting).
SUPPORT
PROTOCOL 1
PREPARING TISSUE FOR CHOLINESTERASE ASSAYS
Tissues should be kept cold during transport, processing, and handling. While ChEs are
stable enzymes, some ChE inhibitors are readily reversible and warmer temperatures can
speed up this process. Such a reversal could result in underestimation or non-detection
of ChE inhibition in a sample. When assaying samples from a given species for the first
time, the appropriate dilution should be determined using a subset of the samples.
ChE can be determined in whole blood, or separated plasma and red blood cells (RBCs).
Serum is not recommended because of the warmer temperature used in processing.
Blood should be collected in the presence of an anticoagulant, preferably heparin or
EDTA. Blood is separated by centrifuging 10 min at 1000 × g, 4◦C. The plasma fraction
supernatant may be clear, white to yellowish in color, and may look milky if lipid levels
are high (such as in laying hens). A reddish color indicates some degree of RBC lysis
has occurred (suggesting that gentler handling of samples is required). One consequence
of RBC lysis is contamination of ChEs between fractions. Plasma itself may be used
directly in ChE determinations or diluted if activity is too high (see Critical Parameters
and Troubleshooting). The cell pack is the RBC fraction. The RBCs should be washed by
resuspending the cell pack with ChE buffer, or a commercial normal saline, at a ratio of
1:1 buffer/RBCs (up to 5:1). The higher ratio of buffer to RBCs provides a more effective
wash. The suspension is recentrifuged 10 min at 1000 × g, 4◦C and the supernatant is
discarded. Whole blood and RBCs are diluted with solubilization buffer (see recipe) to
lyse the RBCs, and to reduce the hemoglobin concentration when performing the colori-
metric assay (see Critical Parameters and Troubleshooting). A typical dilution of human
blood is 1:50 for the colorimetric assay. Some species, such as birds, do not have ChE
in their RBCs, therefore, only the plasma fraction is necessary for ChE determinations.
The plasma is typically assayed undiluted or diluted 1:10. Fresh blood treated with an
anti-clotting agent may be stored for several days in a refrigerator before processing
unless readily rehydrolyzable anti-ChE chemical exposures are suspected. Processed
samples may be stored in a low-temperature (−80◦C) freezer for extended periods.
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 6/16
Determination of Cholinesterase inBlood and Tissue
12.13.6
Supplement 34 Current Protocols in Toxicology
Muscle samples are prepared by removing fascia and fatty tissue. Brain samples are
prepared by removing outer membranes. Since different regions of the brain have different
AChE activities, care must be taken to prepare consistent samples. Homogenize the
entire, or one half of the brain (cut longitudinally) to measure whole brain activity.
Wet weight of samples is determined by blotting them prior to weighing. Samples are
homogenized in solubilization buffer, typically at ratios of 1:5 to 1:50 of tissue to buffer.
Homogenization may be carried out in glass homogenizers with pestles (such as conical
ground glass mortar/ground glass pestle or Potter-Elvehjem grinder with PTFE pestle),
or by motorized tissue grinders. Homogenization should be carried out on ice. Ten to
twenty strokes is sufficient to homogenize soft tissues such as the brain. Firmer tissuessuch as muscle may require up to 50 strokes to complete the homogenization. If not
processed fresh, tissue samples should be stored in a low-temperature (−80◦C) freezer.
Processed samples should be stored in a low-temperature (−80◦C) freezer for extended
periods. Typical dilutions of sample used in ChE determinations are in mammal tissue,
1:500 for the brain and 1:50 for muscle; in bird tissue, 1:500 for the brain and 1:50 for
muscle; and in fish tissue, 1:500 for the brain and 1:500 for muscle.
SUPPORT
PROTOCOL 2
PREPARING FREE SULFHYDRYL STANDARD CURVES
Known amounts of free sulfhydryl (−SH) in the form of reduced glutathione are added
to the colorimetric assay system in the absence of enzyme to determine the change in
absorbance per unit of –SH for the conditions of a specific laboratory (Padilla et al., 1999).
Materials
1 mM glutathione (see recipe)
ChE assay buffer (see recipe)
10.3 mM DTNB color reagent (see recipe)
ATCh substrate (see recipe)
96-well microtiter plates
Microtiter plate reader
1. Add reagents to wells of a 96-well microtiter plate as shown in Table 12.13.3. Run
each concentration of −SH in triplicate.
2. Incubate 5 to 15 min at room temperature.
3. Measure the absorbance of the microtiter plate wells at 412 nm (the commonly
supplied 405-nm narrow-band interference filter is satisfactory).
Table 12.13.3 Glutathione Standard Curve Volumes
–SH (nmol)1 mM glutathione
volume (µ l)
ChE assay buffer
volume (µ l)
DTNB volume
(µ l)
ATCh substrate
volume (µ l)
0 0 280 10 30
2 2 278 10 30
5 5 275 10 30
10 10 270 10 30
15 15 265 10 30
20 20 260 10 30
30 30 250 10 30
50 50 230 10 30
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 7/16
Biochemical andMolecularNeurotoxicology
12.13.7
Current Protocols in Toxicology Supplement 34
Figure 12.13.2 Glutathione standard curve for colorimetric ChE assay. The slope of the regres-
sion line ( absorbance/ −SH nmol) is used in calculating ChE activity. This factor is instrument-
specific and must be determined in each laboratory.
4. Plot the absorbance versus the concentration of −SH.
The slope of the regression is the change in absorbance per nanomole of free sulfhydryl.
5. Use this value in calculating ChE activity (Equ. 12.13.1 and Fig. 12.13.2).
SUPPORT
PROTOCOL 3
PREPARE A SUBSTRATE CONCENTRATION CURVE
The optimal substrate concentration should be verified when measuring ChE activity
in a new species or tissue. It has been found that a concentration of 1 to 2 mM to be
optimal in the mammal and bird species tested, while 2 to 3 mM was optimal in some fish
species. Since AChE exhibits a characteristic substrate inhibition with excess substrate,
it is important to be certain that the substrate concentration is not too high.
Additional Materials ( also see Basic Protocols 1 and 2 )
ATCh or 1 mCi/ml 3H-Ach substrate (see recipes)
ChE assay buffer (see recipe)
Unlabeled ACh iodide stock (Sigma-Aldrich cat. no. A7000)
50 mM sodium phosphate buffer, pH 7 (see recipe)
1. Prepare substrate stock solutions at the concentrations shown in Table 12.13.4.
a. For colorimetric assay: start with the highest ATCh stock concentration listed
(which is ten times the normal stock concentration) and make appropriate dilutions
with ChE assay buffer.
b. For radiometric assay: start with the highest unlabeled ACh stock concentration
listed (which is ten times the normal stock concentration) and make appropriate
dilutions with 50 mM sodium phosphate buffer, pH 7. Add 1 part of 1 mCi/ml3H-ACh stock solution to 100 parts of each of the unlabeled ACh substrate stock
dilutions.
2. Run the assay as usual (see Basic Protocols 1 and 2) with a single sample as the
enzyme source and each substrate concentration in triplicate.
3. Plot the ChE activity versus the log substrate concentration. Determine the optimal
substrate concentration giving the highest ChE activity.
The optimal substrate concentration is represented by the plateau of the curve shown
in Figure 12.13.3 (i.e., 1 to 2 mM ATCh for human blood AChE determined with thecolorimetric assay). Note the drop of AChE activity when the substrate concentration is
>2 mM, demonstrating the characteristic substrate inhibition of AChE.
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 8/16
Determination of Cholinesterase inBlood and Tissue
12.13.8
Supplement 34 Current Protocols in Toxicology
Table 12.13.4 Substrate Test Concentrations
Stock concentration
of substrate (mM)
Colorimetric assay: Final
concentration of substrate
(mM)
Radiometric assay: Final
concentration of substrate
(mM)
1.07 0.1 0.2
2.14 0.2 0.4
3.21 0.3 0.6
5.35 0.5 110.7 1 2
21.4 2 4
32.1 3 6
53.5 5 10
107 10 20
Figure 12.13.3 Acetylthiocholine (ATCh) substrate curve for colorimetric assay. Human blood
AChE was measured over a range of ATCh substrate concentrations. The optimal concentra-
tion is 1 to 2 mM. There is a characteristic substrate inhibition of AChE activity at higher ATCh
concentrations. Values are mean ± SD, n = 3. Adapted from Wilson et al. (1995).
SUPPORT
PROTOCOL 4
USING SPECIFIC INHIBITORS OF ChEs
Specific inhibitors can be used to distinguish between AChE and BChE in a given species.
1,5-Bis(4-allyldimethyl-ammoniumphenyl)pentan-3-one dibromide (BW284c51) in-
hibits AChE and tetraisopropyl-pyrophosphoramide (iso-OMPA) inhibits BChE. Quini-
dine is an inhibitor of mammalian BChE. The appropriate inhibitor concentrations should
be determined by running dose/response curves.
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 9/16
Biochemical andMolecularNeurotoxicology
12.13.9
Current Protocols in Toxicology Supplement 34
Additional Materials ( also see Basic Protocols 1 and 2 )
Inhibitor: 1,5-bis(4-allyldimethyl-ammoniumphenyl)pentan-3-one dibromide(BW284c51) or tetraisopropyl-pyrophosphoramide (iso-OMPA) (see recipes)
1. Prepare inhibitor stock solutions at the concentrations shown in Table 12.13.5.
2. Replace part of buffer volume with inhibitor stock: 10 µ l for radiometric assay or
30 µ l for colorimetric assay. Add all reagents except substrate. Incubate mixture 15
min at room temperature.
3. Add substrate at end of 15 min to start enzyme reaction and continue to assay asusual (see Basic Protocol 1 or 2).
Table 12.13.5 ChE Inhibitor Stock Concentrations
Final inhibitor
concentration (M)
Colorimetric assay
stock concentration
(M)
Radiometric assay
stock concentration
(M)
1.0 × 10 –3 9.7 × 10 –3 8.0 × 10 –3
3.0 × 10 –4 2.9 × 10 –3 2.4 × 10 –3
1.0 × 10 –4 9.7 × 10 –4 8.0 × 10 –4
3.0 × 10 –5 2.9 × 10 –4 2.4 × 10 –4
1.0 × 10 –5 9.7 × 10 –5 8.0 × 10 –5
3.0 × 10 –6 2.9 × 10 –5 2.4 × 10 –5
1.0 × 10 –6 9.7 × 10 –6 8.0 × 10 –6
3.0 × 10 –7 2.9 × 10 –6 2.4 × 10 –6
1.0 × 10 –7 9.7 × 10 –7 8.0 × 10 –7
3.0 × 10 –8 2.9 × 10 –7 2.4 × 10 –7
1.0 × 10 –8 9.7 × 10 –8 8.0 × 10 –8
Figure 12.13.4 Dose-response curve for a specific ChE inhibitor. Iso-OMPA inhibits human
plasma BChE, but not RBC AChE,at 10–4 M. This inhibitor concentration can be used to distinguish
between the two enzymes in a human whole blood sample. Values are mean ± SD, n = 3.
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 10/16
Determination of Cholinesterase inBlood and Tissue
12.13.10
Supplement 34 Current Protocols in Toxicology
4. Plot activity versus inhibitor concentration.
The appropriate inhibitor concentration is the plateau of the curve where activity is lowest (Fig. 12.13.4).
REAGENTS AND SOLUTIONS
Use Milli-Q-purified water or equivalent in all recipes and protocol steps. For common stock
solutions, see APPENDIX 2A; for suppliers, see SUPPLIERS APPENDIX .
3 H-Acetylcholine (ACh) stock solution (1 mCi/ml)
Add 1 ml of 50 mM sodium phosphate buffer, pH 7.0 (see recipe) to 1 mCi 3H-
ACh iodide (Perkin-Elmer cat. no. NET113001MC). Store up to 1 year at −20◦C
desiccated.
3 H-Acetylcholine (ACh) substrate (10 mM ACh; 10 µCi/ml)
68.3 mg unlabeled ACh iodide (Sigma-Aldrich cat. no. A7000)
25.0 ml 50 mM sodium phosphate buffer, pH 7.0 (see recipe)
250 µ l 1 mCi/ml 3H-ACh stock solution (see recipe)
Store up to 1 year at −20◦C
ATCh substrate (10.7 mM acetylthiocholine iodide)
Dissolve 30.8 mg ATCh per 10.0 ml final volume in 0.1 M sodium phosphate buffer,pH 8.0 (see recipe). Store 1 month at −20◦C.
A fresh solution is recommended. It may precipitate if kept on ice during assay.
BW284c51
For 10 –2 M stock: Add 28.3 mg 1,5-bis(4-allyldimethyl-ammoniumphenyl)pentan-3-one dibromide (BW284c51, Sigma-Aldrich cat. no. A9013) in 5.0 ml finalvolume of water
10 –3 M solution: Dilute 10 –2 M BW284c51 stock 1:10 with 0.1 M sodiumphosphatebuffer, pH 8 (see recipe)
Store up to 1 month at 4◦C
CAUTION: BW284c51 is a selective AChE inhibitor and very toxic.
ChE assay buffer
0.1 M sodium phosphate, pH 8.0 (see recipe)
Store up to 6 months at room temperature
Cloudiness indicates fungal or bacterial growth, if this occurs, prepare fresh solution.
DTNB color reagent (10.3 mM)
Dissolve 20.5 mg 5,5-dithiobis-2-nitrobenzoic acid (DTNB) per 5.0 ml final vol-
ume in 0.1 M sodium phosphate buffer, pH 7.0 (see recipe). Store up to 1 month at
−20◦C.
A fresh solution is recommended. It may precipitate if kept on ice during assay.
Eel AChE (100 U/ml)
1000 U eel AChE (Sigma-Aldrich cat. no. C2888)
10.0 ml H2O
Store up to 1 year at –20◦C
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 11/16
Biochemical andMolecularNeurotoxicology
12.13.11
Current Protocols in Toxicology Supplement 34
Fluor
3.0 liters toluene (scintillation-grade)
15.0 g 2,5-diphenyloxazole (PPO)
0.6 g 1,4-bis[5-phenyl-2-oxazoyl]benzene; 2,2-p-phenylene-bis[5-phenyloxazole](POPOP)
330 ml isoamyl alcohol
Store up to 2 years at room temperature
Glutathione stock (1 mM)
3.1 mg glutathione (reduced form; Sigma-Aldrich cat. no. G4251) brought to a
10.0-ml volume with 0.1 M sodium phosphate, pH 8.0 (see recipe). Prepare fresh.
Iso-OMPA
For 10 –2 M tetraisopropylpyrophosoramide (iso-OMPA; Sigma-Aldrich cat. no.
T1505) stock: Add 17.1 mg iso-OMPA in 5.0 ml final volume of water.
For a 10 –3 M iso-OMPA solution: Dilute 10 –2 M stock 1:10 with 0.1 M sodium
phosphate buffer, pH 8 (see recipe). Store 1 month at 4◦C.
CAUTION: Iso-OMPA is a selective BChE inhibitor and extremely hazardous.
Sodium phosphate buffer, 0.1 M (pH 7.0 or 8.0)
Prepare 0.1 M monobasic sodium phosphate (12.0 g/liter in water) and 0.1 M
dibasic sodium phosphate (14.2 g/liter in water). Mix solutions at a ratio of 55 parts
monobasic to 945 parts dibasic for pH 8.0 or 39 parts monobasic to 61 parts dibasic
for pH 7.0. Check pH with a pH meter and adjust with appropriate phosphate stock
solution. Dilute 1:1 with water for 50 mM phosphate buffer. Store for 6 months at
room temperature.
Cloudiness indicates fungal or bacterial growth.
Solubilization buffer
0.5 ml Triton X-100 (0.5% final concentration; Sigma-Aldrich cat. no. T9284)
99.5 ml ChE assay buffer (see recipe)
Store up to 6 months at 4◦C
Stopping mixture
9.45 g monochloroacetic acid (1 M)
2.0 g NaOH (0.5 M)
11.6 g NaCl (2 M)
Bring to a final volume of 100.0 ml with H2O
Store up to 1 year at room temperature
COMMENTARY
Background Information
Acetylcholine (ACh) is an important neu-rotransmitter to humans and animals. A part
of transmission regulation is the destruc-
tion of ACh by special esterases (acetyl-
cholinesterase, AChE, EC 3.1.1.7; nonspe-
cific cholinesterase or pseudocholinesterase,
BChEs, EC 3.1.1.8) that hydrolyze it into
choline and acetic acid (Fig. 12.13.5). In addi-
tion to its presence in the nervous and muscle
systems, AChE and BChE are found in the
blood and other tissues. AChE is found in the
red blood cell (RBC) membranes of mammals.AChE and BChEs are found in the plasma of
some mammals and other vertebrates (only
BChE is present in human plasma; Wilson,
1999, 2001).
ChE and other esterase activities in the
nervous system, their cellular regulation, and
physiological functions were first studied early
in the 20th century. The development of ChE
inhibitors for use as chemical warfare agents
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 12/16
Determination of Cholinesterase inBlood and Tissue
12.13.12
Supplement 34 Current Protocols in Toxicology
Figure 12.13.5 Cholinesterases catalyze the hydrolysis of acetylcholine.
just before World War II and the synthesis of
organophosphate and organocarbamate ChE
inhibitors as pesticides after the war created
a need for rapid and clinically suitable as-
says to screen for ChE inhibiting pesticides
and to monitor human exposures to these
agents. The first ChE assays were research
tools; they relied on slow but precise meth-
ods such as macro-Warburg manometry and
micro-Cartesian divers (Wilson, 1999, 2001).
Three techniques in use today are the delta
pH method of Michel (1949), the radiomet-
ric method of Johnson and Russell (1975),
and the thiocholine method of Ellman et al.
(1961). The delta pH method currently is used
by CHPPM (U.S. Army Center for Health
Promotion and Preventive Medicine), the U.S.
Department of Defense’s monitoring facility,
to keep track of ∼15,000 servicemen and em-
ployees annually. The radiometric and colori-
metric methods presented here are drawn from
the authors’ laboratory.The U.S. Department of Defense chose the
delta pH method of Michel to measure red
blood cell AChEs before the thiocholine-based
Ellman method was developed. The Michel
assay is relatively inexpensive and capable of
standardization using multiple pH meters. It
is useful for a laboratory that does not have
access to automated colorimetric or to radio-
metric instruments. The radiometric method
uses radiolabeled acetylcholine. It is the most
sensitive of the assays but also requires facil-
ities that handle radiolabeled chemicals and
their disposal. Being end-point assays, the pHand radiometric methods are less suitable for
kinetic studies than the Ellman assay. The Ell-
man assay is the most widely used and has
spawned many variants.
It is important to consider the properties of
the ChE inhibitors, which may be present in
exposed tissue samples, whether they are read-
ily or very slowly reversible (Wilson, 1999,
2001). See Nostrandt et al. (1993) for consid-
erations when working with readily reversible
carbamates.
Critical Parameters andTroubleshooting
It is important to establish the enzyme as-
say conditions. A few minutes of testing an as-
say can save untold hours of grief. The assay
conditions for enzymes printed in peer- andnon-reviewed papers may not apply to the lab-
oratory specific systems. Determining the rate
of an enzyme is not quite the same as cleaning
up a residue and running gas chromatogra-
phy with appropriate standards. Enzymes are
catalysts and they are affected by a number
of conditions that are not entirely predictable.
The following short discussion contains sug-
gestions on settingup enzymeassays forChEs.
Use the desired experimental tissues to be
measured to determine the optimum substrate
concentration and range of sample amounts.
The purpose of an enzyme assay is to deter-mine the activity of an enzyme in a sample.
This means that the conditions must be such
that if the amount of sample is doubled, the
activity doubles and if the amount of sample is
halved, then the activity is also halved. If this
does not occur, then the conditions of the assay
must be adjusted so that the sample itself is the
rate-limiting factor. It is important to note that
some widely used commercial ChE kits do not
use optimal reagent conditions (Wilson et al.,
1997). It is critical to establish that the levels
of substrate and other reagents (such as DTNB
in the Ellman method) are not rate limiting inthe assay. Use the values presented here as a
starting point.
Basic Protocol 11. Any compound in the sample that ab-
sorbs at 410 nm can interfere with the as-
say (e.g., hemoglobin in blood samples). A
small amount of such a compound will have
a negligible effect since its absorbance will
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 13/16
Biochemical andMolecularNeurotoxicology
12.13.13
Current Protocols in Toxicology Supplement 34
not increase over time (and, therefore, will not
add to the A /min). A large amount of inter-
fering compound will have a relatively large
absorbance that could mask the smaller in-
creased absorbance due to ATCh hydrolysis.
Whole blood or RBC samples should be di-
luted so that the initial absorbance reading in
the assay is <1.0.
2. Free sulfhydryls present in the sample
can react directly with DTNB to form the col-
ored TNB. Check this by using control tissue-
only blanks.
3. Adjusting sample activity.
The r 2 value of the slope is routinely≥0.99.
A value lower than this is seen when activity is
too low (near the noise level of the sensitivity
of the assay)or activity is too high (absorbance
near the upper limit of detection of the instru-
ment or substrate is becoming rate limiting).
If the activity is too low, the value of the
slope will be highly variable and prone to er-
ror. Change the timer in the plate reader proto-
col to give longer intervals between repeatedreadings. This will increase the sensitivity of
the assay system.
If the activity is too high, the measured
absorbance can become too high and the ob-
served slope can become nonlinear. Dilute the
sample to give an appropriate level of ac-
tivity (i.e., final absorbance should not ex-
ceed 3.0 and its slope should be linear; r 2 >
0.99). Higher activities can be measured with
a shorter reading interval, but this is not prefer-
able. Blank values are more variable and can
appear higher when measured with a shorter
interval (e.g., 1 min rather than 2 min).4. The quality of the sample is another fac-
tor that could produce a low r 2 value. Par-
ticulates in the sample may scatter light and
interfere with the absorbance measurements.
These can be removed by centrifugation, but
ensure that the ChE fraction of the sample is
not removed. Ensure that samples are mixed
well and homogenous in the microtiter plate
well, especially viscous samples such as sol-
ubilized RBCs. These can also scatter light if
not mixed well.
Basic Protocol 21. The assay is useful when interferences
to the Ellman assay exist (such as high
hemoglobin or sample particulates that remain
in the aqueous phase) or high sensitivity is re-
quired. Although this assay is simple enough
and can be used on a routine basis in labo-
ratories possessing a scintillation counter, the
problems associated withthe useof radioactiv-
ity, including the cost of removing hazardous
waste, promotes its use only for special situa-
tions.
2. When running the samples in triplicate,
up to 30 sets can be assayed at one time. Given
the large number of vials being prepared, it
is easy to lose track during a pipetting step.
Tilting the rack, while holding the vials, makes
it possible to readily detect the absence of as
low as 10 µ l of solution by comparing the
meniscus from one vial to another.
3. It is crucial that the toluene-based fluor
is used. Common commercial fluors have
been designed to avoid using solvents such
as toluene, and they contain surfactants to
achieve homogenous mixtures. This would
ruin the radiometric assay, which relies on the
phase separation between the aqueous buffer
(containing the intact labeled substrate) and
the solvent fluor (containing the labeled reac-
tion product, acetic acid).
4. Check the level of counts in the blanks.
The cpm in the blank should be ≤5% of the
total cpm measured in the eel AChE vials.A higher percentage in the blank indicates a
breakdown of the substrate during storage. If
this is observed, the assays should be repeated
using a new substrate preparation.
5. Some compounds (e.g., colored com-
pounds) may enter the toluene phase of the
scintillation mixture and cause quenching and
interfere with an accurate assessment of the
cpm. In this case, the dpm should be deter-
mined to account for quenching. This can be
done by using an external standard present
in most scintillation counters (consult specific
instrument’s manual). This will increase thecounting time per vial. The dpm are used in
place of the cpm in the calculations. It is pru-
dent to alwaysdetermine the cpmand usethem
in calculating the ChE activities.
Expressing activityBlood activities are generally expressed in
terms of volume per milliliter of whole blood
or plasma, or per milliliter RBC based on
hematocrit determinations. Activities of tissue
are usually expressed in terms of weight per
gram of wet weight or per milligram protein.
Species and developmental differencesDifferences in AChE/BChE content be-
tween species, tissues, and ages are all too
often ignored, leading to gross errors in exper-
imental analysis. For example, many determi-
nations of rodent blood (an important matter
in toxicology studies) assume that the AChE is
in the RBC and the serum contains only BChE
activity. Instead, almost half the serum activity
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 14/16
Determination of Cholinesterase inBlood and Tissue
12.13.14
Supplement 34 Current Protocols in Toxicology
Table 12.13.6 ChE Values of Various Species Determined According to These Protocols
Species Tissue n Total ChEa AChEa BChEa Assayb Reference
Mammals
Human
( Homo sapiens)
Whole blood 10 5.32 ± 0.65 C Unpublished
RBC 10 12.9 ± 2.2
Plasma 10 1.61 ± 0.29
Rhesus monkey
( Macaca mulatta)
Whole blood 4 2.64 ± 0.17 R Unpublished
Plasma 4 0.065 ± 0.023
Dog
(Canis familiarus)
Whole blood 4 0.87 ± 0.084 R Unpublished
Plasma 4 0.34 ± 0.028
Dairy cow
( Bos taurus)
Whole Blood 20 1.98 ± 0.37 C Arrieta
(2003)
Swiss mouse
( Mus musculus)
Plasma 5 2.07 ± 0.08 C Burruel et al.,
(2000)
BirdsRed-tailed hawk
( Buteo jamaicensis)
Plasma 44 0.66 ± 0.03c 0.14 ± 0.01c 0.52 ± 0.02c C Stein et al.
(1998)
American kestrel
( Falco sparverius)
Plasma 86 1.9 ± 0.05c 1.6 ± 0.05c 0.26 ± 0.01c C
Pigeon
(Columba livia)
Plasma 23 1.65 ± 0.26 C Unpublished
Brain 23 282 ± 18.5
White Leghorn
chicken (Gallus
domesticus)
Plasma 24 0.22 ± 0.01 C Henderson
et al. (1992)
Muscle 3 1.26 ± 0.27 Wilson et al.(1988)
Brain 3 296 ± 12
Japanese quail
(Coturnix coturnix
japonica)
Muscle
culture
64 51.7 ± 7.8c R Wilson and
Nieberg
(1983)
Fish
Mudsucker
(Gillichthys
mirabilis)
Brain 122 217 ± 31 C Unpublished
Medaka (larva)
(Oryzias latipes)
Retina 3 × 10
pooled
126 ± 2.3c C Hamm et al.
(1998)
continued
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 15/16
Biochemical andMolecularNeurotoxicology
12.13.15
Current Protocols in Toxicology Supplement 35
Table 12.13.6 ChE Values of Various Species Determined According to These Protocols, continued
Species Tissue n Total ChEa AChEa BChEa Assayb Reference
Amphibians
Pacific tree frog
( Hyla regilla)
Whole body,
bred 8◦C
30 28.2 ± 10.2 C Johnson et al.
(2005)
Whole body,
bred 19◦C
30 42.3 ± 17.3
aUnits areµmol/min/ml for blood fractions, and nmol/min/mg protein for other tissues. Values are means ± SD.bC, colorimetric assay; R, radiometric assay.cValues = SEM.
in the rat is AChE (Wilson, 1999, 2001). Sera
from embryos of species such as the bovine
may differ from that of the adult, in this case,
the bovine fetal blood is high in AChE and the
adult serum has little of either AChE or BChE
(Arrieta et al., 2003).
VariabilityAll samples are routinely run in triplicate
and the mean activity rate is used for further calculations. If the standard deviation is >10%
of the mean, the sample is routinely re-run.
Samples with very low activity (i.e., highly
inhibited) will be near the noise level of the
assay. Activities near zero are likely to be more
variable and will usually not meet the 10%
threshold criterion.
StandardsA triplicate set of bovine RBC ghost stan-
dards prepared by the laboratory (Arrieta et al.,
2003) is routinely run with each plate in the
colorimetric assay. Its use or a preparation of electric eel AChE or other commercial stan-
dards is recommended.
ReagentsIf the assay does not appear to be working
and the reagents are suspect, discard reagents
and prepare fresh reagents. Do not waste time
checking reagents.
Anticipated Results
Basic Protocol 1The basic unit of data determined from
the colorimetric assay is the calculated
slope of the kinetic reaction, with units of
change in absorbance per minute. The sub-
strate blank provides the background rate of
non-enzymatic substrate hydrolysis, with a
typical value of 0.001. The minimum slope
for a sample well should be at least three times
the background, or 0.003. The maximum lin-
ear slope for a sample well is ∼0.25. This
yields a change of absorbance of 2.5 over the
10-min assay time, near the limit of accurate
absorbance measurements. Typical slopes are
in the range of 0.01 to 0.15. It is important to
check the correlation coefficient of the slope as
an indication of a successful assay (see Critical
Parameters and Troubleshooting).
Basic Protocol 2The cpm determined in the radiometric
assay range from ∼3000 in the blanks to
∼100,000 in the eel AChE total hydrolysis
controls. The cpm in the sample should range
from three times background to 50% of the
total (eel) cpm, i.e., 10,000 to 50,000 cpm.
Examples of ChE activity levels in human,
other mammalian, avian, fish, and amphibian
tissues determined using these assay protocols
are shown in Table 12.13.6.
Time Considerations
Sample preparationPreparing samples can take up to 1.5 hr
depending upon the type of sample (blood or
solid tissue), type of preparation (centrifuga-
tion or homogenization), and dilution. Label
sample tubes prior to beginning sample prepa-
ration.
Basic Protocol 1Preparing fresh substrate and colorimetric
reagents takes∼30 min.Pipettingreagents and
samples into a 96-well microtiter plate takes
∼20 min. The time to acquire the kinetic read-
ings depends on the time interval and number
of readings (the typical six readings at 2-min
intervals takes 10 min, the first reading is time
zero).
7/28/2019 tx1213
http://slidepdf.com/reader/full/tx1213 16/16
Determination of Cholinesterase inBlood and Tissue
12.13.16
Supplement 35 Current Protocols in Toxicology
Basic Protocol 2Preparation of radiometric reagents is time
consuming and they should be prepared ahead
of time. The radioactive substrate is typically
storedfrozen and thawed for the assay. Adding
reagents and samples takes ∼15 min per rack
of vials. Assay time takes 15 to 40 min, de-
pending on activity levels. Adding stopping
reagent and fluor takes ∼10 min per rack of
vials. Phase separation takes 30 min. Scintil-
lation counting can take 5 to 10 min per vial
and is typically done overnight.
Literature CitedArrieta, D., Ramirez, A., DePeters, E., Bosworth,
D., and Wilson, B.W. 2003. Bovine red bloodcell ghost cholinesterase as a monitoring stan-dard. Bull. Environ. Contam. Toxicol. 71:447-452.
Burruel, V.R., Raabe, O.G., Overstreet, J.W.,Wilson, B.W., and Wiley, L.M. 2000. Paternaleffects from methamidophos administration inmice. Toxicol. Appl. Pharmacol. 165:148-157.
Ellman, G.L., Courtney, K.D., Andres, V. Jr., andFeather-Stone, R.M. 1961. A new and rapid col-orimetric determination of acetylcholinesteraseactivity. Biochem. Pharmacol. 7:88-95.
Hamm, J.T., Wilson, B.W., and Hinton, D.E. 1998.Organophosphate-induced acetylcholinesteraseinhibition and embryonic retinal cell necrosis invivo in the teleost (Oryzias latipes). Neurotoxi-cology 19:853-869.
Henderson, J.D., Higgins, R.J., Dacre, J.C., andWilson, B.W. 1992. Neurotoxicity of acute andrepeated treatments of tabun, paraoxon, diiso-propyl fluorophosphate and isofenphos to thehen. Toxicology 72:117-129.
Johnson, C.D. and Russell, R.L. 1975. Rapid sim-ple radiometric assay for cholinesterase, suit-able for multipledeterminations. Anal. Biochem.64:229-238.
Johnson, C.S., Schwarzbach, S.E., Henderson,J.D., Wilson, B.W., and Tjeerdema, R.S. 2005.Influence of water temperature on acetyl-cholinesterase activity in the Pacific tree frog( Hyla regilla). Environ. Toxicol. Chem. 24:2074-2077.
Michel, H.O. 1949. Electrometric method for thedetermination of red blood cell and plasmacholinesterase activity. J. Lab. Clin. Med.34:1564-1568.
Nostrandt, A.C., Duncan,J.A.,and Padilla, S. 1993.A modified spectrophotometric method appro-priate for measuring cholinesterase activity intissue from carbaryl-treated animals. Fundam. Appl. Toxicol. 21:196-203.
Padilla, S., Lassiter, T.L., and Hunter, D. 1999.Biochemical measurement of cholinesterase ac-tivity. In Methods in Molecular Medicine, Vol.22: Neurodegeneration Methods and Protocols.(J. Harry and H.A. Tilson, eds.) pp. 237-245.Humana Press Inc., Totowa, N.J.
Stein, R.W., Yamamoto, J.T., Fry, D.M., andWilson, B.W. 1998. Comparative hematologyand plasma biochemistry of red-tailed hawksand American kestrels wintering in California. J. Raptor Res. 32:163-169.
Wilson, B.W. 1999. Cholinesterases. In ClinicalChemistry of Laboratory Animals. (F. Quimbyand W. Loeb, eds.) pp. 430-440. Taylor andFrancis Inc., Philadelphia.
Wilson, B.W. 2001. Cholinesterases. In Handbookof Pesticide Toxicology; Volume 2. Agents.(W.J. Hayes Jr. and E.R. Laws Jr. eds.) pp. 967-985. Academic Press Inc., San Diego.
Wilson, B.W. and Nieberg, P.S. 1983. Recoveryof acetylcholinesterase forms in quail mus-cle cultures after intoxication with diisopropy-lfluorophosphate. Biochem. Pharmacol. 32:911-918.
Wilson, B.W., Sanborn, J.R., O’Malley, M.A.,
Henderson, J.D., and Billitti, J.R. 1997. Mon-itoring the pesticide-exposed worker. Occup. Med. 12:347-363.
Wilson, B.W., Henderson, J.D., Chow, E.,Schreider, J., Goldman, M., Culbertson, R., andDacre, J.C. 1988. Toxicity of an acute dose of agent VX and other organophosphorus esters inthe chicken. J. Toxicol. Environ. Health 23:103-113.
Wilson, B.W., Padilla, S., Sanborn, J.R.,Henderson,J.D., and Billitti, J.E. 1995. Clinical bloodcholinesterase measurements for monitoringpesticide exposures. In Enzymes of theCholinesterase Family. (D.M. Quinn, A.S.Balasubramanian, B.P. Doctor, and P. Taylor,eds.) pp. 329-336. Plenum Press, New York.
Key ReferencesEllman et al., 1961. See above.
Original method paper for the colorimetric assay.
Johnson and Russell, 1975. See above.
Original method paper for the radiometric assay.
Wilson, 2001. See above.
Review of cholinesterase structure and function,distribution, determinations, inhibitions, and reac-tivations, and risk assessment.
Internet Resources
http://chppm.com/ Website for reaching analytical techniques used bythe U.S. Department of Defense including the delta pH ChE method.